D. Grove

发表

Diversion of HIV-1 vaccine–induced immunity by gp41-microbiota cross-reactive antibodies

T. Kepler, S. Hammer, H. Liao, 2015, Science.

Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections

Mila Lebedeva, John Heitman, Persephone Borrow, 2009, Journal of Virology.

Analysis of the HVTN 702 Phase 2b-3 HIV-1 vaccine trial in South Africa assessing RV144 antibody and T-cell correlates of HIV-1 acquisition risk.

Lindsay N. Carpp, J. Kublin, M. McElrath, 2022, The Journal of infectious diseases.

A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204)

W. Blattner, D. Montefiori, S. Kalams, 2011, PloS one.

Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120/MF59 in Adults

M. Andrasik, J. Kublin, M. McElrath, 2021, The New England journal of medicine.

Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial

S. Hammer, R. Gottardo, S. Buchbinder, 2017, The Journal of infectious diseases.

Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine.

Holly Janes, David C Montefiori, Peter B Gilbert, 2013, The New England journal of medicine.

Intentions to Use Preexposure Prophylaxis Among Current Phase 2B Preventive HIV-1 Vaccine Efficacy Trial Participants

S. Hammer, M. Andrasik, J. Fuchs, 2013, Journal of acquired immune deficiency syndromes.

A descriptive analysis of transgender participants in phase 1-2a trials of the HIV Vaccine Trials Network (HVTN) in the United States and Peru.

M. Andrasik, S. Karuna, D. Grove, 2019, Vaccine.

Daily Vaginal Swabs and Mobile Phone Sex Report for Assessing HIV Virion Exposure Prospectively Among a Cohort of Young Sexually Active Women in South Africa (HVTN 915)

M. Andrasik, J. Kublin, M. McElrath, 2019, Journal of acquired immune deficiency syndromes.

A Sequential Phase 2b Trial Design for Evaluating Vaccine Efficacy and Immune Correlates for Multiple HIV Vaccine Regimens

Peter B Gilbert, Lawrence Corey, Steven G Self, 2011, Statistical communications in infectious diseases.

HVTN 505 Statistical Analysis Plan : Protocol V 6 ( Extended Follow-Up ) October 3 , 2014 Study Statisticians

H. Janes, P. Gilbert, D. Grove, 2014 .

Using Mobile Technology (pMOTAR) to Assess Reactogenicity: Protocol for a Pilot Randomized Controlled Trial

J. Andriesen, B. Maharaj, D. Grove, 2018, JMIR research protocols.

Diversion of HIV-1 vaccine–induced immunity by gp41-microbiota cross-reactive antibodies

T. Kepler, S. Hammer, B. Haynes, 2015, Science.

Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South Africa

M. Andrasik, L. Bekker, Yunda Huang, 2023, AIDS and Behavior.